RAP MC is closer to $150M, whilst ours (MEB) sits at $50M. I do...

RAP MC is closer to $150M, whilst ours (MEB) sits at $50M.

I do believe we have immediate upside with pending FDA approval and with products that are already commercialized.

We just need one large $1M plus contract and we will be off and running. Credit to management for not succumbing to pressure handing out our unique product on the cheap - it is a valuable aid/tool for companies where the cost of mental illness can run into the tens of millions at a minimum for big multinationals, Ross Jones (Jacobs) proved this in his blog post recently. Think of the value we can create for these companies.

However, back to the comparison with RAP, I am happy for RAP's MC to grow as this can only be a good thing for MEB once the re-rate occurs.

Mr.G